Navigation Links
FHSSA and the African Palliative Care Association Launch the First-Ever Pain Management Initiative in The Gambia, Kenya, and Malawi
Date:2/9/2011

ALEXANDRIA, Va., Feb. 9, 2011 /PRNewswire-USNewswire/ -- With generous funding totaling more than $220,000 FHSSA and the African Palliative Care Association are partnering to improve pain management among palliative care patients receiving care in hospitals in The Gambia, Kenya, and Malawi.

These three countries were selected because they each have well-established national palliative care organizations, strong clinical leadership, historical success with related projects, and sound professional relationships with APCA and FHSSA staff/leadership.

FHSSA's executive director, John Mastrojohn, traveled to Uganda this week to participate in kick-off meetings for the project.

FHSSA and APCA identified a set of challenges for the management of pain in The Gambia, Kenya, and Malawi. Hospital-based health care workers sometimes have a limited understanding of the palliative care concept and the need for palliative care services.

"Often, physicians are not comfortable in effectively prescribing opioids, such as morphine. This can be due to lack of skills in pain assessment and management, coupled with fears around the use of these powerful medications," said Mastrojohn.

The project framework is based on the success of a pilot project in Uganda that was endorsed by the World Health Organization and the Ugandan Ministry of Health. Objectives include:

  1. To create awareness of, support for and prioritization of palliative care delivery among hospital management/administrators.
  2. To train hospital physicians in pain assessment and management, with a central focus on opioid use.
  3. To sensitize other health care workers in the hospitals and community to support palliative care service delivery.

Funding was provided by Astellas Pharma US, Inc. , AstraZeneca Pharmaceuticals LP, Daiichi Sankyo, Inc., Endo Pharmaceuticals Inc., Lundbeck Inc, OSI Pharmaceuticals Inc., Pharmaceutical Research and Manufacturers of America (PhRMA), Grunenthal, and The Brin Wojcicki Foundation.

Learn more about the work of FHSSA at www.fhssa.org.

The Winter issue of FHSSA's "Focus on Compassion" newsletter is available online at http://www.fhssa.org/files/public/Quarterly/Focus_Winter_2011.pdf. Contact:Susan MessinaDirector of Communications and Special EventsOffice of Philanthropy (National Hospice Foundation and FHSSA)571-275-4324smessina@nationalhospicefoundation.org
'/>"/>

SOURCE FHSSA
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
2. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
3. US FDA Grants Orphan Drug Status to Immtechs Pafuramidine for Treatment of African Sleeping Sickness
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
6. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
7. Immtech Receives $5.1 Million to Further African Sleeping Sickness Clinical Trials
8. Tampax and Always Launch Protecting Futures Program Dedicated to Helping African Girls Stay in School
9. New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline
10. Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
11. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... YORK , Feb. 23, 2017  The ... 330.6 million by 2021 from USD 275.9 million ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... increasing spending on pharmaceutical R&D, and growth in ... driving the market growth for particle counters. On ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Disorder Drugs Price Analysis and Strategies - 2016" report to ... ... - 2016, provides drug pricing data and benchmarks in the global ... What are the key drugs marketed ...
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
Breaking Medicine Technology:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... The ... national conference convening academic faculty engaged in or interested in palliative care education and ... will be held in North County San Diego on Sept. 28 and 29, ...
(Date:2/24/2017)... Farifax, VA (PRWEB) , ... February 24, 2017 , ... ... winners for excellence in radiology marketing programs at the annual Building Better ... the Worthington Renaissance Fort Worth Hotel in Fort Worth, Texas. Nine awards are given ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... official 2017 partnership with The Jensie Gran Fondo of Marin. For the second ... rays with Thinksport’s broad-spectrum, mineral-based sunscreen. , “We are thrilled to provide our ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rare Disease ... will be participating in Rare Disease Day events, hosted by the Rare Disease ... Disease Report, a website, weekly e-newsletter and quarterly publication, will be conducting interviews ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
Breaking Medicine News(10 mins):